|
|
|
|
|
|
|
|
|
Webinar: In vivo CAR-T and gene editing: the manufacturing reality behind the promise
|
Explore manufacturing realities shaping in vivo CAR-T development in this Lonza webinar. Learn how RNA-LNPs and viral vectors compare under scale-up pressure, where analytical and process challenges emerge, and what separates scalable programs from stalled ones. Through case studies, Lonza experts share lessons learned across both delivery platforms to help teams build stronger manufacturing strategies. Click here to learn more.
|
|
|
|
|
|
Video | Invetech
|
With the demand for specialized equipment that can effectively meet evolving needs, learn about innovative solutions and gain insights into incorporating scalability from the early stages of equipment development.
|
|
|
|
|
|
Webinar | Lonza
|
Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.
|
|
|
|
|
|
Webinar | MilliporeSigma
|
Explore essential QC strategies in AAV gene therapy and learn how to address rcAAV detection, viral clearance per ICH Q5A, and impurity profiling using NGS to meet evolving regulatory demands.
|
|
|
|
|
|
Webinar | Andelyn Biosciences
|
An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.
|
|
|
|
|
|
Video | Cell & Gene
|
In this Cell & Gene Live, Anthony Blaszczyk, Ph.D., U.S. Pharmacopeia, and Basak Clements, Ph.D., biomatria, joined our Chief Editor Erin Harris to discuss efforts to build better particulate guidance with new best practices and cross-industry collaboration, as particulates remain a complex, unsolved challenge.
|
|
|
|
|
|
Webinar | inSeption Group
|
Follow along as industry experts unpack the underlying causes of these challenges and consider whether clinical oversight monitors represent a necessary evolution or simply an additional layer of complexity.
|
|
|
